Additional glucose-lowering drug to reach glycaemic target in cardiac patient - Case 1 (update May 2020)

Question Title

* 1. Given the need to intensify the glucose-lowering regimen (not at target glycated haemoglobin) and the clinical characteristics of the patient, which could be an appropriate drug to be added to the ongoing therapeutic scheme?

A: a sulphonylurea

B: increased metformin dosage

C: acarbose

D: a DPP-4 inhibitor

E: a GLP-1 R agonist (liraglutide or semaglutide)

Question Title

* 2. In the case that the patient refuses the injectable therapy, which could be a valuable alternative?

A: a sulphonylurea

B: increased metformin dosage

C: acarbose

D: a DPP-4 inhibitor

E: an SGLT-2 inhibitor

To see the correct answers please click "Next"